Alphabet has raised its 2026 capital expenditure guidance to as much as $205 billion, driving Q2 free cash flow negative and prompting investor concerns over the profitability of its AI strategy amid threats to its core search business.
Futures for Canada's main stock index rose on Monday, tracking a global equity rally as a pause in U.S.-Iran hostilities sent crude oil prices tumbling, boosting investor sentiment ahead of a key week for central bank policy and corporate earnings.
Shares of Delta Air Lines rose after a report revealed the carrier rejected a 2025 merger proposal from rival United Airlines, highlighting its strategic value amid significant antitrust concerns.
Shares of major U.S. carriers gained in premarket trading Monday, benefiting from a significant drop in crude oil prices following reports of potential de-escalation in the Middle East.
Shares of the biopharmaceutical company jumped after it detailed a clear path to a New Drug Application submission for its pulmonary arterial hypertension drug, seralutinib, and reacquired the asset's full global rights.
Late-stage drug developer Apnimed Inc. has filed for a U.S. initial public offering to raise up to $160 million as it seeks FDA approval for its lead sleep apnea treatment, Oxnimbi.
The German luxury automaker announced a second restructuring package with labor representatives that includes an additional 5,000 job reductions by 2035, alongside a €2.1 billion investment in key German plants.
A wide array of U.S. companies, from Nike and Coca-Cola to Abbott Labs and OpenAI, have reported significant cybersecurity incidents this year. The attacks involve data theft, ransomware, and operational disruptions, prompting a new White House initiative to address the growing threat.
Nuclear startup Antares Nuclear has raised $470 million in a funding round co-led by Paradigm and Caffeinated Capital to develop and deploy microreactors for U.S. military installations by 2028.
